6:28 PM
Jan 15, 2013
 |  BC Extra  |  Financial News

Alcobra files for IPO

Alcobra Ltd. (Tel Aviv, Israel) proposed to raise up to $17.3 million in an IPO on NASDAQ underwritten by Aegis Capital. Alcobra's lead compound is MG01CI, an extended-release...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >